Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testing effect of a drug using multiple nested models for the dose-response.

C Baayen1,2, P Hougaard1, C B Pipper2

  • 1H. Lundbeck A/S, Biometrics Division, Ottiliavej 9, 2500 Valby, Denmark.

Biometrics
|February 10, 2015
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The EKiTE network (epidemiology in kidney transplantation - a European validated database): an initiative epidemiological and translational European collaborative research.

BMC nephrology·2019
Same author

Sequential trials in the context of competing risks: Concepts and case study, with R and SAS code.

Statistics in medicine·2019
Same author

Factors of selection and failure of ambulatory incisional hernia repair: A cohort study of 1429 patients.

Journal of visceral surgery·2018
Same author

'25-Hydroxyvitamin D, Autoantigenic and Total Antibody Concentrations: Results from a Danish Case-control Study of Newly Diagnosed Patients with Childhood Type 1 Diabetes and their Healthy Siblings'.

Scandinavian journal of immunology·2017
Same author

Outpatient groin hernia repair: assessment of 9330 patients from the French "Club Hernie" database.

Hernia : the journal of hernias and abdominal wall surgery·2017
Same author

No association between vitamin D levels around time of birth and later risk of developing oligo- and polyarticular juvenile idiopathic arthritis: a Danish case-cohort study.

Scandinavian journal of rheumatology·2016
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
Same journal

Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

Biometrics·2026
Same journal

Discussion on "INTACT: a method for integration of longitudinal physical activity data from multiple sources" by Jingru Zhang, Erjia Cui, Hongzhe Li, and Haochang Shou.

Biometrics·2026
See all related articles

This study introduces a new statistical method for drug dose-finding trials. It effectively selects the best dose-response model without needing prior parameter estimates, improving drug development.

Area of Science:

  • Pharmacometrics
  • Biostatistics
  • Drug Development

Background:

  • Drug dose selection typically relies on Phase II dose-finding trials comparing multiple doses against a placebo.
  • Existing statistical methods include separate dose-placebo comparisons or model-based approaches, each with limitations.
  • Model-based methods require correct model specification, while separate comparisons may not evaluate all tested doses.

Purpose of the Study:

  • To propose an alternative multiple testing procedure for selecting dose-response models in drug development.
  • To develop a method that evaluates a set of candidate models against each other to identify the most suitable one.
  • To avoid the need for a priori parameter estimates in model selection.

Main Methods:

  • A novel multiple testing procedure is introduced to compare candidate dose-response models.
Keywords:
Dose-findingMCP-ModModel selectionMultiple testing

Related Experiment Videos

  • The method evaluates models against each other to select a single final model.
  • It controls the Type I error rate for selecting overly complex models.

    • Main Results:

    • The proposed method does not require pre-specified parameter estimates for candidate models.
    • It offers a robust approach to model selection in dose-finding studies.
    • The procedure effectively manages the risk of choosing an inappropriate, complex model.

    Conclusions:

    • The developed multiple testing procedure provides a flexible and reliable alternative for dose-response model selection in drug development.
    • This approach enhances the statistical rigor of dose-finding trials by allowing data-driven model selection.
    • The method addresses limitations of existing techniques, particularly regarding model misspecification and parameter estimation.